CARDIOGENIC SHOCK POST AMI

Monday, March 10, 2025

3:30 PM – 4:30 PM ET

Moderator(s)

Gregg W. Stone, MD, FACC, MSCAI

Physician
Mount Sinai
New York, New York, United States

Disclosure(s): Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Vascular Dynamics, Pulnovo, V-wave: Research support to Mount Sinai Hospital (Ongoing); Apollo Therapeutics, Cardiac Success, Occlutech, Millennia Biopharma, RCE, Ablative Solutions, Abbott: Consultant (Terminated); Boehringer Ingelheim: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Shockwave, Biosense-Webster, Bioventrix: Research support to Mount Sinai Hospital (Terminated); Valfix, Zoll, HeartFlow, Shockwave, Ancora, Impulse Dynamics, Adona Medical, Oxitope, HighLife, Elixir, Elucid Bio, Aria, Alleviant, FBR Medical: Consultant (Ongoing)

Panel Discussant(s)

Lindsey Cilia, MD

Co-Director of Complex Coronary Therapeutics Program Interventional Cardiologist
Inova Heart and Vascular Institute/Virginia Heart
Falls Church, Virginia, United States

Disclosure(s): No financial relationships to disclose
Ramesh Daggubati, MD, FACC, FSCAI

Vice Chair of the Department of Cardiology & Chief of Interventional Cardiology
JW Ruby Memorial Hospital, West Virginia University
Morgantown, West Virginia, United States

Disclosure(s): medtronic.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Dean J. Kereiakes, MD, FACC, MSCAI

Chairman, The Christ Hospital Heart and Vascular Institute; Medical Director, The Christ Hospital Research Institute; Professor of Clinical Medicine, The Ohio State University
The Christ Hospital Health Network
Cincinnati, Ohio, United States

Disclosure(s): Ablative Solutions, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Elixir Medical Corporation: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); JC Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Orchestra Biomed: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Sino Medical Sciences Technology, Inc.: Consultant (Ongoing)
Tanveer Rab, MD, FACC, MSCAI

Professor
Emory University
Decatur, Georgia, United States

Disclosure(s): No financial relationships to disclose
Michael J. Rinaldi, MD

Director Structural Heart Program
Sanger Heart and Vascular Institute/Atrium Health
Charlotte, North Carolina, United States

Disclosure(s): Abbott Vascular,: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); abiomed: Consultant (Ongoing); boston scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); edwards: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); shockwave: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
George W. Vetrovec, MD, MACC, MSCAI

Professor Emeritus
VCU Pauley Heart Center
Richmond, Virginia, United States

Disclosure(s): Abiomed: Consultant (Ongoing)
Ron Waksman, MD, MSCAI

Director, Cardiovascular Research and Advanced Education
MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Washington, District of Columbia, United States

Disclosure(s): Abbott Vascular: Grant/Research Support (Ongoing); Biotronik: Consultant (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Chiesi USA: Grant/Research Support (Ongoing)

Disclosure(s):

Gregg W. Stone, MD, FACC, MSCAI: Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Vascular Dynamics, Pulnovo, V-wave: Research support to Mount Sinai Hospital (Ongoing); Apollo Therapeutics, Cardiac Success, Occlutech, Millennia Biopharma, RCE, Ablative Solutions, Abbott: Consultant (Terminated); Boehringer Ingelheim: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Shockwave, Biosense-Webster, Bioventrix: Research support to Mount Sinai Hospital (Terminated); Valfix, Zoll, HeartFlow, Shockwave, Ancora, Impulse Dynamics, Adona Medical, Oxitope, HighLife, Elixir, Elucid Bio, Aria, Alleviant, FBR Medical: Consultant (Ongoing)

Lindsey Cilia, MD: No financial relationships to disclose

Ramesh Daggubati, MD, FACC, FSCAI: medtronic.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Dean J. Kereiakes, MD, FACC, MSCAI: Ablative Solutions, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Elixir Medical Corporation: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); JC Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Orchestra Biomed: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Sino Medical Sciences Technology, Inc.: Consultant (Ongoing)

Tanveer Rab, MD, FACC, MSCAI: No financial relationships to disclose

Michael J. Rinaldi, MD: Abbott Vascular,: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); abiomed: Consultant (Ongoing); boston scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); edwards: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); shockwave: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

George W. Vetrovec, MD, MACC, MSCAI: Abiomed: Consultant (Ongoing)

Ron Waksman, MD, MSCAI: Abbott Vascular: Grant/Research Support (Ongoing); Biotronik: Consultant (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Chiesi USA: Grant/Research Support (Ongoing)